Results from a study of nearly 60,000 individuals suggest those at higher risk of developing Alzheimer's disease due to family history may demonstrate changes in memory performance as early as their 20s. Researchers from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and the University of Arizona gathered the data through an online word-pair memory test called MindCrowd, one of the world's largest scientific assessments of how healthy brains function.
One of the largest studies on out-of-pocket costs for nursing home care finds prices are high and rising faster than other medical care and consumer prices, reports a team of health policy researchers.
A move by the White House in 2017 -- decried by many health policy analysts as an attempt to undercut the Affordable Care Act (ACA) -- had unanticipated consequences that improved the affordability of health insurance for Marketplace enrollees. The findings show that the Trump Administration's cut of the ACA's cost-sharing reduction payments to health insurers caused insurance providers to compensate by changing the distribution of premiums in ways that increase federal government subsidies to Marketplace enrollees.
A team of researchers from Carnegie Mellon University has made a breakthrough in the field of noninvasive robotic device control. Using a noninvasive brain-computer interface (BCI), researchers have developed the first-ever successful mind-controlled robotic arm exhibiting the ability to continuously track and follow a computer cursor.
Thousands of adults in Arkansas lost insurance coverage in the first six months after Medicaid work requirements were implemented, with no change in employment, according to a new study from Harvard T.H. Chan School of Public Health.
This partnership will employ Shimmer's Verisense™ wearable sensors platform, which has been designed specifically for use in clinical research, with ClearSky algorithms and machine learning to transform wearables data into actionable insights for central nervous system (CNS) diseases.
A reconfigurable 'body-on-a-chip' model could transform drug development by simultaneously measuring compound efficacy and toxicity, for both target cells and other organs, such as the heart and liver, for both parent drugs and its metabolites. The findings demonstrate the same results determined from testing patients in clinical studies, without the need of animal studies, demonstrating the ability of a body-on-a-chip model to truly revolutionize biomedical research and personalized medicine.
In a new study, researchers demonstrate that assessment tools capturing implicit signs of word knowledge among those with severe autism like eye movement can be more accurate than traditional assessments of vocabulary, pointing the way toward better inventions and spurring much needed new research.
A new study on the behavior of water in cancer cells shows how methods usually limited to physics can be of great use in cancer research. The researchers, Murillo Longo Martins and Heloisa N. Bordallo at the Niels Bohr Institute, University of Copenhagen, have shown how a combination of neutron scattering and thermal analysis can be used to map the properties of water in breast cancer cells.
A drug that helps regulate bone development has boosted growth rates in children with achondroplasia -- the most common type of dwarfism -- in a trial by Melbourne's Murdoch Children's Research Institute. Phase 2 trial results in children aged 5 to 14 years are published today in the New England Journal of Medicine. The project is now in Phase 3 to test the drug, vosoritide, in a larger group of patients aged 5 to 18 years.